Logo
DCA

Madrigal Pharmaceuticals, Inc.

MDGL•Healthcare•Biotechnology
553,48 $US
+1.46%
Letzter Preis
553,48 $US
2026-07-17
24h Änderung
+1.46%
7.95 USD
Volumen
528.309
Gehandelte Anteile
Datenzuverlässigkeit
Hoch
4892 Punkte (19 Jahre)

Kursentwicklung

Starten Sie eine Simulation mit diesem Asset

MDGL

Globale Parameter

Verfügbare Daten von 6.2.2007 bis 17.7.2026

Fundamentalanalyse

New
CAGR (5y)
432.66%
Revenue Growth
Net Margin
-30.08%
Profitability
ROE
-47.83%
Return on Equity
Debt / EBITDA
0.00
Solvency
PEG Ratio
-
Valuation vs Growth
Rev. Growth (TTM)
126.80%
Current Trend
Technischer Fokus
MDGL
30d-Volatilität
89.99%
Abstand zur MA50
7.60%
Abstand zur MA200
10.09%
Abstand zum ATH
-8.19%
Momentum 3M
4.03%
Risiko-Score
N/A

Moderate Volatilität. Momentum neutral.

Über Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Website besuchen ↗
In diesen Wert investieren
Kaufen bei Saxo Bank
🏦Regulierter Broker
🌍Globaler Marktzugang
📈Profi-Tools

Werbelink. Kapital unterliegt Risiken.

Technische Analyse & Risiko

Schlüsselkennzahlen

CAGR2.89%
Volatilität89.99%
Max Drawdown-44.19%

Momentum : MDGL

Indicateur synthétique
PEURNEUTREAVIDITÉ
53
Neutral

Risikoanalyse

VaR (95%)-5.88%
DCA Gesundheit
54/100

Jüngste Geschichte (60 Tage)

DatumSchlusskursVolumen
2026-07-17553,48 $US528.309
2026-07-16545,53 $US238.336
2026-07-15550,25 $US259.456
2026-07-14536,86 $US238.239
2026-07-13531,00 $US287.877
2026-07-10536,70 $US292.717
2026-07-09560,01 $US379.018
2026-07-08565,40 $US468.200
2026-07-07545,36 $US318.400
2026-07-06529,48 $US230.981
2026-07-02528,10 $US207.167
2026-07-01514,39 $US303.742
2026-06-30536,95 $US382.646
2026-06-29527,28 $US446.029
2026-06-26512,65 $US2.500.271
2026-06-25513,79 $US359.992
2026-06-24509,76 $US399.750
2026-06-23513,43 $US259.719
2026-06-22512,88 $US277.158
2026-06-18505,75 $US486.971
2026-06-17499,86 $US260.767
2026-06-16501,19 $US256.730
2026-06-15499,76 $US280.065
2026-06-12480,77 $US202.326
2026-06-11474,28 $US274.274
2026-06-10471,32 $US280.768
2026-06-09476,89 $US285.809
2026-06-08467,28 $US262.727
2026-06-05486,98 $US185.192
2026-06-04492,83 $US153.462
2026-06-03488,15 $US261.264
2026-06-02452,86 $US425.217
2026-06-01481,23 $US234.002
2026-05-29497,27 $US322.287
2026-05-28515,96 $US235.808
2026-05-27527,67 $US144.100
2026-05-26524,28 $US260.000
2026-05-22517,26 $US156.952
2026-05-21513,59 $US201.606
2026-05-20513,47 $US312.903
2026-05-19511,82 $US255.784
2026-05-18522,23 $US322.877
2026-05-15523,69 $US222.453
2026-05-14539,89 $US334.998
2026-05-13518,87 $US366.756
2026-05-12510,26 $US217.857
2026-05-11497,03 $US305.905
2026-05-08510,04 $US377.506
2026-05-07534,86 $US383.168
2026-05-06539,73 $US512.464
2026-05-05502,47 $US331.045
2026-05-04518,66 $US180.170
2026-05-01513,72 $US186.480
2026-04-30517,39 $US224.318
2026-04-29518,58 $US151.065
2026-04-28516,69 $US213.334
2026-04-27520,09 $US209.961
2026-04-24512,39 $US200.289
2026-04-23518,74 $US330.184
2026-04-22529,14 $US197.797

Verwandte Assets

Eli Lilly and CompanyLLY.NEHealthcareEli Lilly and CompanyLLYHealthcareJohnson & JohnsonJNJHealthcareAbbVie Inc.ABBV.NEHealthcareJohnson & JohnsonJNJ0.FHealthcareAbbVie Inc.ABBVHealthcare